Empresa Celyad Oncology SA OTC Markets
Acciones
CYADY
US1512052002
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 18
Ventas por actividad
EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cardiology
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Ventas por región
EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Europe and United States
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Michel Lussier
FOU | Founder | 67 | 24/07/07 |
David Georges
DFI | Director of Finance/CFO | - | 01/01/19 |
Eytan Breman
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/15 |
An Phan
LAW | General Counsel | 49 | 01/09/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Michel Lussier
FOU | Founder | 67 | 24/07/07 |
Hilde Windels
CHM | Chairman | 59 | 07/05/18 |
Serge Goblet
BRD | Director/Board Member | - | 01/01/08 |
Director/Board Member | 53 | 20/01/22 | |
Director/Board Member | - | - | |
Director/Board Member | 50 | 06/05/20 | |
Sage Mandel
BRD | Director/Board Member | - | - |
Marina Udier
BRD | Director/Board Member | - | 11/01/11 |
Ami Patel Shah
BRD | Director/Board Member | - | 08/12/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 41 428 572 | 38 267 083 ( 92,37 %) | 0 | 92,37 % |
Información de la empresa
Celyad Oncology SA
Axis Business Park Rue André Dumont 9
1435, Mont-Saint-Guibert
+32 1 039 41 00
http://www.celyad.comSector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,59 % | 44,44 mil M | |
+42,78 % | 40,03 mil M | |
-10,62 % | 37,68 mil M | |
+29,92 % | 31,46 mil M | |
-9,23 % | 27,29 mil M | |
+12,34 % | 26,29 mil M | |
+41,53 % | 13,8 mil M | |
+31,49 % | 12,46 mil M | |
-7,40 % | 11,26 mil M |